Literature DB >> 21308522

Staphylococcal toxic shock syndrome: mechanisms and management.

Jonathan A Silversides1, Emma Lappin, Andrew J Ferguson.   

Abstract

Staphylococcal toxic shock syndrome is a rare complication of Staphylococcus aureus infection in which bacterial toxins act as superantigens, activating very large numbers of T cells and generating an overwhelming immune-mediated cytokine avalanche that manifests clinically as fever, rash, shock, and rapidly progressive multiple organ failure, often in young, previously healthy patients. The syndrome can occur with any site of S. aureus infection, and so clinicians of all medical specialties should have a firm grasp of the presentation and management. In this article, we review the literature on the pathophysiology, clinical features, and treatment of this serious condition with emphasis on recent insights into pathophysiology and on information of relevance to the practicing clinician.

Entities:  

Year:  2010        PMID: 21308522     DOI: 10.1007/s11908-010-0119-y

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  48 in total

Review 1.  Toxic shock syndrome and bacterial superantigens: an update.

Authors:  J K McCormick; J M Yarwood; P M Schlievert
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

2.  Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period.

Authors:  Patrick M Schlievert; Timothy J Tripp; Marnie L Peterson
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

3.  Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome.

Authors:  Thu A Chau; Michelle L McCully; William Brintnell; Gary An; Katherine J Kasper; Enrique D Vinés; Paul Kubes; S M Mansour Haeryfar; John K McCormick; Ewa Cairns; David E Heinrichs; Joaquín Madrenas
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

4.  Usefulness of antimicrobial resistance pattern for detecting PVL- or TSST-1-producing meticillin-resistant Staphylococcus aureus in a French university hospital.

Authors:  Houssein Gbaguidi-Haore; Michelle Thouverez; Gérard Couetdic; Pascal Cholley; Daniel Talon; Xavier Bertrand
Journal:  J Med Microbiol       Date:  2009-06-25       Impact factor: 2.472

5.  Comparison of dopamine and norepinephrine in the treatment of shock.

Authors:  Daniel De Backer; Patrick Biston; Jacques Devriendt; Christian Madl; Didier Chochrad; Cesar Aldecoa; Alexandre Brasseur; Pierre Defrance; Philippe Gottignies; Jean-Louis Vincent
Journal:  N Engl J Med       Date:  2010-03-04       Impact factor: 91.245

Review 6.  Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses.

Authors:  P M Schlievert
Journal:  J Allergy Clin Immunol       Date:  2001-10       Impact factor: 10.793

7.  Staphylococcal infection and toxin production in chronic rhinosinusitis.

Authors:  Lobna M el-Fiky; Nagwa Khamis; Badr El Din Mostafa; Ahmed M Adly
Journal:  Am J Rhinol Allergy       Date:  2009 May-Jun       Impact factor: 2.467

8.  Detection of antibodies to Staphylococcus aureus Toxic Shock Syndrome Toxin-1 using a competitive agglutination inhibition assay.

Authors:  V Javid Khojasteh; M T Rogan; V Edwards-Jones; H A Foster
Journal:  Lett Appl Microbiol       Date:  2003       Impact factor: 2.858

9.  Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France.

Authors:  Geraldine Durand; Michèle Bes; Helene Meugnier; Mark C Enright; Françoise Forey; Nadia Liassine; Aline Wenger; Ken Kikuchi; Gerard Lina; François Vandenesch; Jerome Etienne
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

10.  Analysis of superantigenic toxin Vbeta T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock.

Authors:  T Ferry; D Thomas; T Perpoint; G Lina; G Monneret; I Mohammedi; C Chidiac; D Peyramond; F Vandenesch; J Etienne
Journal:  Clin Microbiol Infect       Date:  2008-03-27       Impact factor: 8.067

View more
  12 in total

1.  Prevalence of toxin genes in consecutive clinical isolates of Staphylococcus aureus and clinical impact.

Authors:  T-X Nhan; R Leclercq; V Cattoir
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-12       Impact factor: 3.267

2.  Staphylococcus aureus, Toll-like receptors, superantigens, and their derivatives.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2012-10       Impact factor: 4.599

Review 3.  Danger points, complications and medico-legal aspects in endoscopic sinus surgery.

Authors:  W Hosemann; C Draf
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2013-12-13

Review 4.  Fracture-related infection.

Authors:  T Fintan Moriarty; Willem-Jan Metsemakers; Mario Morgenstern; Marloes I Hofstee; Alejandro Vallejo Diaz; James E Cassat; Britt Wildemann; Melissa Depypere; Edward M Schwarz; R Geoff Richards
Journal:  Nat Rev Dis Primers       Date:  2022-10-20       Impact factor: 65.038

5.  What Are the Immune Responses That Allow Us to Live With Incurable Bone Infection, and How Can They Be Augmented to Improve Outcomes After Prosthetic Joint Infection?

Authors:  Edward M Schwarz
Journal:  J Bone Miner Res       Date:  2022-04-25       Impact factor: 6.390

6.  Staphylococcal toxic shock syndrome in a lactating mother with breast abscess: A case report.

Authors:  Kamal Pandit; Sushil Khanal; Prabhat Adhikari; Samaj Adhikari; Subhash Prasad Acharya
Journal:  Ann Med Surg (Lond)       Date:  2020-07-22

7.  Toxic Shock Syndrome after Surgery: Case Presentation and Systematic Review of the Literature.

Authors:  Karel-Bart Celie; David L Colen; Stephen J Kovach
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-05-29

8.  The Management of Staphylococcal Toxic Shock Syndrome. A Case Report.

Authors:  Victoria Bîrluțiu; Ofelia Criștiu; Marius Baicu; Rareș Mircea Bîrluțiu
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-05-09

9.  Chimeric anti-staphylococcal enterotoxin B antibodies and lovastatin act synergistically to provide in vivo protection against lethal doses of SEB.

Authors:  Mulualem E Tilahun; Alan Kwan; Kannan Natarajan; Megan Quinn; Ashenafi Y Tilahun; Chen Xie; David H Margulies; Barbara A Osborne; Richard A Goldsby; Govindarajan Rajagopalan
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

Review 10.  The Continuing Threat of Methicillin-Resistant Staphylococcus aureus.

Authors:  Márió Gajdács
Journal:  Antibiotics (Basel)       Date:  2019-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.